Product Information
UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH is a generic product labeled by Prasco Laboratories, priced at $4.8733 per EA under NDC 66993013497. Its NADAC has been published 54 times since Jun 18, 2025.
UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH
umeclidinium bromide and vilanterol trifenatateStrength
62.5; 25 ug/1; ug/1
Manufacturer
Prasco LaboratoriesNDC
66993013497
Classification
Generic
Dosage Form
POWDER
Route
RESPIRATORY (INHALATION)
Last Updated
6/17/2026
Active Ingredients
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA203975On Market Since
4/11/2025
Pharmacological Classes
Price Statistics
The NADAC for UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH has been published 54 times since Jun 18, 2025, and over the history we have for it it has risen 4.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.8733 per EA |
|---|---|
| All-time high | $4.9841 (Dec 10, 2025) |
| All-time low | $4.6565 (Jun 18, 2025) |
| 52-week high | $4.9841 |
| 52-week low | $4.6565 |
| Median price | $4.8778 |
| Average price | $4.8713 |
| Largest weekly change | +2.8% (Sep 17, 2025) |
| Weeks tracked | 54 |
| Tracking since | Jun 18, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH?
The current National Average Drug Acquisition Cost (NADAC) for UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH, manufactured by Prasco Laboratories, is $4.8733 per EA (NDC 66993013497), effective Jun 24, 2026.
How has the price of UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH changed over time?
Over the history we have for it, the NADAC for UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH has risen 4.7%. It has been tracked across 54 weekly CMS publications since Jun 18, 2025.
What are the highest and lowest recorded NADAC prices for UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH?
Since Jun 18, 2025, the NADAC for UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH has ranged from a low of $4.6565 (Jun 18, 2025) to a high of $4.9841 (Dec 10, 2025), with a median of $4.8778 per EA.
Are there cheaper alternatives to UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH, but none are currently priced below it.
Who manufactures UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH?
UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH (NDC 66993013497) is labeled by Prasco Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification